187 related articles for article (PubMed ID: 7994038)
1. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism.
Kaplanski G; Farnarier C; Kaplanski S; Porat R; Shapiro L; Bongrand P; Dinarello CA
Blood; 1994 Dec; 84(12):4242-8. PubMed ID: 7994038
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13.
Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K
Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation.
Bertini R; Sironi M; Martin-Padura I; Colotta F; Rambaldi S; Bernasconi S; Ghezzi P; Haskill SJ; Liu D; Mantovani A
Cytokine; 1992 Jan; 4(1):44-7. PubMed ID: 1377516
[TBL] [Abstract][Full Text] [Related]
5. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event.
Kaplanski G; Porat R; Aiura K; Erban JK; Gelfand JA; Dinarello CA
Blood; 1993 May; 81(10):2492-5. PubMed ID: 8490165
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
[TBL] [Abstract][Full Text] [Related]
7. Monocyte modulation of endothelial leukocyte adhesion molecules.
Weill D; Wautier JL; Dosquet C; Wautier MP; Carreno MP; Boval B
J Lab Clin Med; 1995 Jun; 125(6):768-74. PubMed ID: 7539477
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide.
Hijiya N; Miyake K; Akashi S; Matsuura K; Higuchi Y; Yamamoto S
Pathobiology; 2002; 70(1):18-25. PubMed ID: 12415188
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.
Vidal-Vanaclocha F; Alvarez A; Asumendi A; Urcelay B; Tonino P; Dinarello CA
J Natl Cancer Inst; 1996 Feb; 88(3-4):198-205. PubMed ID: 8632494
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear cell-conditioned medium enhances thrombin-stimulated PGI2 production by human umbilical vein endothelial cells in culture.
Watanabe K; Tanaka H; Tamaru N; Yoshida M
Prostaglandins Leukot Essent Fatty Acids; 1993 Sep; 49(3):675-81. PubMed ID: 8248272
[TBL] [Abstract][Full Text] [Related]
12. [The inhibition effect of interleukin-1 receptor antagonist on interleukin-1 alpha-induced intercellular adhesion molecule-1 expression on orbital fibroblasts and adhesion of peripheral blood mononuclear cells].
Liu GQ; Wu ZY; Yang HS; Zheng JL; Lin Z
Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):528-32. PubMed ID: 14766082
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.
Granowitz EV; Vannier E; Poutsiaka DD; Dinarello CA
Blood; 1992 May; 79(9):2364-9. PubMed ID: 1533323
[TBL] [Abstract][Full Text] [Related]
14. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
Tilg H; Vannier E; Vachino G; Dinarello CA; Mier JW
J Exp Med; 1993 Nov; 178(5):1629-36. PubMed ID: 7693853
[TBL] [Abstract][Full Text] [Related]
16. E-selectin expression induced by pancreas-carcinoma-derived interleukin-1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells.
Kaji M; Ishikura H; Kishimoto T; Omi M; Ishizu A; Kimura C; Takahashi T; Kato H; Yoshiki T
Int J Cancer; 1995 Mar; 60(5):712-7. PubMed ID: 7532161
[TBL] [Abstract][Full Text] [Related]
17. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.
Marin V; Montero-Julian FA; Grès S; Boulay V; Bongrand P; Farnarier C; Kaplanski G
J Immunol; 2001 Sep; 167(6):3435-42. PubMed ID: 11544336
[TBL] [Abstract][Full Text] [Related]
18. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
Brown EA; Dare HA; Marsh CB; Wewers MD
Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
[TBL] [Abstract][Full Text] [Related]
19. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Levesque MC; Haynes BF
J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
[TBL] [Abstract][Full Text] [Related]
20. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
